Skip to main content
TipRanks
Go Ultimate75% OFF

Rosetta Genomics (ROSGQ) Financial Statements

63 Followers

Rosetta Genomics Financial Overview

Rosetta Genomics's market cap is currently $593. The company's EPS TTM is ―; its P/E ratio is 0.00; Rosetta Genomics has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.

Financial overview
Dec 16
Income Statement
Total Revenue$ 9.23M
Gross Profit$ 1.79M
Operating Income$ -15.66M
EBITDA$ -15.32M
Net Income$ -16.23M
Balance Sheet
Cash & Short-Term Investments$ 6.16M
Total Assets$ 11.96M
Total Debt$ 3.79M
Net Debt$ -2.37M
Total Liabilities$ 7.54M
Stockholders' Equity$ 4.42M
Cash Flow
Free Cash Flow$ -10.59M
Operating Cash Flow$ -10.37M
Investing Cash Flow$ 823.00K
Financing Cash Flow$ 3.26M

Currency in USD

Rosetta Genomics Earnings and Revenue History

-24M-12M012M-177 %-176 %-175 %-174 %EarningsProfit Margin2016RevenueEarningsProfit Margin

Rosetta Genomics Liabilities to Assets

05M10M15M62 %63 %64 %65 %LiabilitiesLiabilities to Assets2016AssetsLiabilitiesLiabilities to Assets

Rosetta Genomics Cash Flow

-12.5M-10M-7.5M-5M-2.5M02.5M5M2016OperatingInvestingFinancing

Rosetta Genomics Forecast EPS vs Actual EPS